NMIBC risk calculators: How useful are they for the practicing urologist and how can their clinical utility be improved? - Abstract

The natural history of non-muscle invasive bladder cancer (NMIBC) in individual patients can be unpredictable.

Although there are known clinical and molecular factors associated with tumor recurrence and progression, it is challenging to reconcile these data during a typical patient encounter within a busy clinic. The authors discuss the European Organization for Research and Treatment of Cancer's risk tables along with other models for predicting prognosis in patients with NMIBC. The authors also describe their advantages and disadvantages and the barriers to using these risk models in daily clinical practice and provide a future perspective on prognostic models.

Written by:
Lammers RJ, Sylvester RJ, Lee CT, Witjes JA.   Are you the author?
Department of Urology, Radboud University Medical Centre, Geert Grooteplein Zuid 10 (659), P.O. Box 9101, Nijmegen 6500 HB, The Netherlands.

Reference: Urol Clin North Am. 2013 May;40(2):155-64.
doi: 10.1016/j.ucl.2013.01.002


PubMed Abstract
PMID: 23540774

UroToday.com Bladder Cancer Section